Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23


Access the latest science & engage with your peers on social media 

Follow #ESMO22 on Facebook, Twitter, LinkedIn, Instagram and YouTube.

Share the science and be part of the conversation  

  • The official hashtag is #ESMO22: using it will allow you to join the conversation around the Congress 
  • Permission is not needed to use the hashtag

#ESMO22 content

  • A total of two Twitter handles may be included in the ESMO Congress 2022 content, e.g. posters, presentations. Handles to be included can be the ones of first author/presenter and the sponsor.
  • It is strongly advised to also use the Congress hashtag (#ESMO22) to allow for increased visibility and engagement during Congress.

The European Society for Medical Oncology (ESMO) welcomes discussions related to cancer issues on social media. 

Statements or opinions expressed in posts reflect the views of the contributor, and do not reflect the official views of ESMO, unless otherwise noted. ESMO cannot respond to every comment. Likes and follows on social media channels are not endorsements. ESMO assumes no liability for sensitive information posted by users.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.